Trimethoprim/sulfamethoxazole and cephalexin combination therapy in hidradenitis suppurativa patients: A series of 16 cases

By sjmartinez • June 19, 2023

Masson R, Seivright J, Shih T, Bennett RG, Hogeling M, Shi VY, Hsiao JL. Trimethoprim/sulfamethoxazole and cephalexin combination therapy in hidradenitis suppurativa patients: A series of 16 cases. JAAD Case Rep. 2023 May 5;37:1-4. doi: 10.1016/j.jdcr.2023.04.025. PMID: 37332359; PMCID: PMC10275732.

Tags: cephalexin, combination therapy, Dermatology, efficacy, hidradenitis suppurativa, Outcomes, Publications, safety, Treatment, trimethoprim/sulfamethoxazole

Treatment of severe perinuclear antineutrophil cytoplasmic antibody-associated vasculitis with efgartigimod

Ghafari-Saravi A, Haussmann A, Wu J, Cheng K. Treatment of severe perinuclear antineutrophil cytoplasmic antibody-associated vasculitis with efgartigimod. JAAD Case Rep. 2024 Mar 15;47:68-71. doi:[...]

Stigmatization and Mental Health Impact of Chronic Pediatric Skin Disorders

Paller AS, Rangel SM, Chamlin SL, Hajek A, Phan S, Hogeling M, Castelo-Soccio L, Lara-Corrales I, Arkin L, Lawley LP, Funk T, Castro Porto Silva[...]

Sustained Improvements in Clinical and Patient-Reported Outcomes and Quality of Life Through 5 Years Among Ixekizumab-Treated Patients with Complete Clearance of Scalp Psoriasis by Week 60

Egeberg A, Hawkes JE, Somani N, Burge R, See K, Gallo G, McKean-Matthews M, Gooderham M, Han G, Armstrong A. Sustained Improvements in Clinical and[...]